Date published: 2026-4-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM71B Inhibitors

FAM71B inhibitors encompass a range of compounds designed to modulate the function of FAM71B, a protein implicated in essential cellular processes. The primary action of these inhibitors centers on targeting the pathways and interactions central to FAM71B's role within the cell. Given FAM71B's involvement in vesicular trafficking, interaction with Golgi apparatus components, and its potential role in cellular transport mechanisms, these inhibitors target these specific areas to affect the protein's functionality. The diverse mechanisms of action of these inhibitors allow for a broad approach to modulating FAM71B's role in cellular processes. One aspect of FAM71B's functionality lies in its potential role in vesicular trafficking and Golgi apparatus function. Inhibitors in this category aim to modulate these processes by influencing the protein's interactions and its role in transport mechanisms within the cell. By altering the dynamics of vesicle formation or their fusion with target membranes, or by affecting the functional integrity of the Golgi apparatus, these inhibitors can change the biological processes in which FAM71B is involved. This modulation is crucial, as it impacts essential cellular functions like protein sorting, modification, and the maintenance of cellular homeostasis. Additionally, the regulation of intracellular transport pathways by FAM71B is another primary target for these inhibitors. By influencing the protein's interaction with components of the transport machinery, the inhibitors can alter the signaling cascade initiated by these components, which is especially relevant for understanding and influencing cellular communication and transport processes. Moreover, the involvement of FAM71B in various signaling pathways provides another avenue for inhibition. These pathways are integral to numerous cellular activities, including cell proliferation, differentiation, and survival. Inhibitors that affect these pathways can thereby influence FAM71B's role in these processes. By targeting key enzymes and steps within these pathways, the inhibitors can modulate the downstream effects mediated by FAM71B. This method of inhibition highlights the complex interplay between various signaling pathways in cellular function and FAM71B's role within these pathways. In summary, FAM71B inhibitors represent a group of compounds with the ability to modulate the function of FAM71B through diverse mechanisms. By targeting vesicular trafficking, Golgi apparatus interactions, and various signaling pathways, these inhibitors can alter the fundamental processes in which FAM71B is involved. This modulation is significant for understanding the role of FAM71B in cellular signaling and the broader implications of its function in the maintenance of cellular homeostasis. The diverse mechanisms of action of these inhibitors reflect the multifaceted nature of FAM71B's role in cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts the structure and function of the Golgi apparatus, which could possibly inhibit FAM71B's role in vesicular trafficking and Golgi-associated processes.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin, a polyether antibiotic, alters Golgi apparatus functioning and could possibly inhibit FAM71B's activity in Golgi-associated processes.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Nocodazole disrupts microtubules, which are essential for vesicle transport, and could possibly inhibit FAM71B's role in vesicular trafficking.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D inhibits actin polymerization, crucial for vesicle movement, and could possibly inhibit FAM71B-associated vesicular transport.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore inhibits dynamin, essential for vesicle scission, and could possibly inhibit FAM71B's role in vesicular trafficking.

SCH 58261

160098-96-4sc-204272
sc-204272A
10 mg
50 mg
$195.00
$825.00
(1)

Pitstop 2 inhibits clathrin-mediated endocytosis, and could possibly affect processes where FAM71B is involved.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein, a tyrosine kinase inhibitor, can affect various signaling pathways and might possibly inhibit FAM71B's function.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

NSC 23766 inhibits Rac1, a small GTPase, and could possibly impact FAM71B's function in cell signaling and transport.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, can alter intracellular signaling pathways, potentially inhibiting FAM71B's function.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Latrunculin A disrupts actin filaments, essential for vesicular trafficking, and could possibly inhibit FAM71B's activity in this process.